MEDICENNA THERAPEUTICS CORP (MDNA)
CA58490H1073 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to MDNA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.88. This target is 1735.48% above the current price.
MDNA was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about MDNA.
In the previous month the buy percentage consensus was at a similar level.
MDNA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-08 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-06-23 | Oppenheimer | Maintains | Outperform |
| 2022-06-23 | HC Wainwright & Co. | Maintains | Buy |